Publication | Open Access
Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine
21
Citations
17
References
2019
Year
The results of this study do not support pharmacogenetic CYP2D6 screening to accelerate dose adjustment for nortriptyline and venlafaxine in older patients with depression.
| Year | Citations | |
|---|---|---|
Page 1
Page 1